T-Cell NK-Cell Engaging Bispecific Antibodies and Forecast Market

List of Tables
Table 1. Key Players of T-Cell & NK-Cell Engaging Bispecific Antibodies in Global Market
Table 2. Top T-Cell & NK-Cell Engaging Bispecific Antibodies Players in Global Market, Ranking by Revenue (2022)
Table 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Companies, 2018-2023
Table 5. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Companies, (ml), 2018-2023
Table 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Price (2018-2023) & (US$/ml)
Table 8. Global Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Product Type
Table 9. List of Global Tier 1 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2018-2023
Table 15. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2024-2029
Table 16. By Application ? Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2018-2023
Table 20. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2024-2029
Table 21. By Region ? Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2018-2023
Table 25. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2024-2029
Table 26. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2018-2023
Table 29. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2024-2029
Table 30. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2018-2023
Table 33. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2024-2029
Table 34. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2018-2023
Table 37. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2024-2029
Table 38. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2018-2023
Table 41. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2024-2029
Table 42. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2018-2023
Table 45. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2024-2029
Table 46. AbbVie Company Summary
Table 47. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 48. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 49. AbbVie Key News & Latest Developments
Table 50. Astellas Pharma Company Summary
Table 51. Astellas Pharma T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 52. Astellas Pharma T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 53. Astellas Pharma Key News & Latest Developments
Table 54. GEMoaB Monoclonals Company Summary
Table 55. GEMoaB Monoclonals T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 56. GEMoaB Monoclonals T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 57. GEMoaB Monoclonals Key News & Latest Developments
Table 58. Immunocore Company Summary
Table 59. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 60. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 61. Immunocore Key News & Latest Developments
Table 62. Molecular Partners Company Summary
Table 63. Molecular Partners T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 64. Molecular Partners T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 65. Molecular Partners Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 68. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 69. Roche Key News & Latest Developments
Table 70. AstraZeneca Company Summary
Table 71. AstraZeneca T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 72. AstraZeneca T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 73. AstraZeneca Key News & Latest Developments
Table 74. Merck & Co. Company Summary
Table 75. Merck & Co. T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 76. Merck & Co. T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 77. Merck & Co. Key News & Latest Developments
Table 78. Pfizer Company Summary
Table 79. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 80. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 81. Pfizer Key News & Latest Developments
Table 82. Eli Lilly Company Summary
Table 83. Eli Lilly T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 84. Eli Lilly T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 85. Eli Lilly Key News & Latest Developments
Table 86. IGM Biosciences Company Summary
Table 87. IGM Biosciences T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 88. IGM Biosciences T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 89. IGM Biosciences Key News & Latest Developments
Table 90. Novartis Company Summary
Table 91. Novartis T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 92. Novartis T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 93. Novartis Key News & Latest Developments
Table 94. BenHealth Biopharmaceuticals Company Summary
Table 95. BenHealth Biopharmaceuticals T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 96. BenHealth Biopharmaceuticals T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 97. BenHealth Biopharmaceuticals Key News & Latest Developments
Table 98. CytomX Therapeutics Company Summary
Table 99. CytomX Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 100. CytomX Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 101. CytomX Therapeutics Key News & Latest Developments
Table 102. Janssen Company Summary
Table 103. Janssen T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 104. Janssen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 105. Janssen Key News & Latest Developments
Table 106. Lava Therapeutics Company Summary
Table 107. Lava Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 108. Lava Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 109. Lava Therapeutics Key News & Latest Developments
Table 110. MacroGenics Company Summary
Table 111. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 112. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 113. MacroGenics Key News & Latest Developments
Table 114. Maverick Therapeutics Company Summary
Table 115. Maverick Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 116. Maverick Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 117. Maverick Therapeutics Key News & Latest Developments
Table 118. VBL Therapeutics Company Summary
Table 119. VBL Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 120. VBL Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 121. VBL Therapeutics Key News & Latest Developments
Table 122. Amgen Company Summary
Table 123. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 124. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 125. Amgen Key News & Latest Developments
Table 126. T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity (ml) of Key Manufacturers in Global Market, 2021-2023 (ml)
Table 127. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Capacity Market Share of Key Manufacturers, 2021-2023
Table 128. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production by Region, 2018-2023 (ml)
Table 129. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production by Region, 2024-2029 (ml)
Table 130. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Opportunities & Trends in Global Market
Table 131. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers in Global Market
Table 132. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints in Global Market
Table 133. T-Cell & NK-Cell Engaging Bispecific Antibodies Raw Materials
Table 134. T-Cell & NK-Cell Engaging Bispecific Antibodies Raw Materials Suppliers in Global Market
Table 135. Typical T-Cell & NK-Cell Engaging Bispecific Antibodies Downstream
Table 136. T-Cell & NK-Cell Engaging Bispecific Antibodies Downstream Clients in Global Market
Table 137. T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors and Sales Agents in Global Market
List of Figures
Figure 1. T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Type in 2022
Figure 2. T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Application in 2022
Figure 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2029 (US$, Mn)
Figure 7. T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Global Market: 2018-2029 (ml)
Figure 8. The Top 3 and 5 Players Market Share by T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue in 2022
Figure 9. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
Figure 11. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
Figure 12. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/ml), 2018-2029
Figure 13. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
Figure 15. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
Figure 16. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/ml), 2018-2029
Figure 17. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
Figure 20. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
Figure 21. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
Figure 22. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
Figure 23. US T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 24. Canada T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
Figure 27. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
Figure 28. Germany T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 29. France T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 31. Italy T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 32. Russia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
Figure 36. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
Figure 37. China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 38. Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 41. India T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
Figure 43. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
Figure 44. Brazil T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
Figure 48. Turkey T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 49. Israel T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 51. UAE T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 52. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity (ml), 2018-2029
Figure 53. The Percentage of Production T-Cell & NK-Cell Engaging Bispecific Antibodies by Region, 2022 VS 2029
Figure 54. T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Value Chain
Figure 55. Marketing Channels